{"url_path":"/sec/inbs/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 OTHER INFORMATION**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1725430/0001493152-26-022617-index.html","accession_number":"0001493152-26-022617","cik":"0001725430","ticker":"INBS","issuer_name":"INTELLIGENT BIO SOLUTIONS INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1725430/0001493152-26-022617-index.html","primary_entity_key":"0001725430","primary_entity_name":"INTELLIGENT BIO SOLUTIONS INC."},"word_count":57,"has_tables":true,"body_markdown":"**ITEM\n5. OTHER INFORMATION**\n\n \n\nDuring\nthe period covered by this Quarterly Report on Form 10-Q, none of the Company’s directors or executive officers has adopted or\nterminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement (each as defined in Item 408 of Regulation S-K\nunder the Securities Exchange Act of 1934, as amended).\n\n \n\n29"}